GlassScriptPhysician profile
Michael J Ramsey
NPI 1821089871
$949.26
in general payments reported to CMS, 2019-2025
20 companies · $215 in 2025
The $215 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $11.54 · 2021: $98.45 · 2022: $180 · 2023: $57.60 · 2024: $225 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $158.95 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $141.85 | 2019-2022 | |
| Pfizer INC. | $82.92 | 2022-2025 | |
| Alcresta Therapeutics, INC. | $76.00 | 2025 | Relizorb |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Corium, LLC | $58.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.90 | 2020-2021 | |
| Tolmar, INC. | $42.61 | 2025 | Fensolvi |
| Merck Sharp & Dohme LLC | $34.56 | 2024-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Neos Therapeutics, LP | $31.31 | 2019 | |
| Genzyme Corporation | $30.19 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $27.98 | 2023 | |
| Sanofi Pasteur INC. | $27.69 | 2019-2024 | |
| Masimo Corporation | $26.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.44 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $18.05 | 2024 | Dupixent |
| Glaxosmithkline, LLC. | $15.62 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.71 | 2025 | Jornay Pm |
| Novartis Pharmaceuticals Corporation | $12.32 | 2019 | |
| Shire North American Group INC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.